Status:
RECRUITING
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Prostate Cancer
Lower Urinary Tract Symptoms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrentl...
Detailed Description
The investigators propose a prospective trial to investigate pre-radiation holmium laser enucleation (HoLEP) in men with bothersome lower urinary tract symptoms (LUTS) and prostate cancer who have ele...
Eligibility Criteria
Inclusion
- Patients must be 18 years of age or older
- Patients must have bothersome lower urinary tract symptoms (LUTS), defined by American Urological Association Symptom Score (AUA SS) of greater than or equal to 15 and/or as defined by a post-void residual of greater than or equal to 350mL and/or as defined by catheter dependence
- Patients must be diagnosed with prostate cancer by pathological tissue analysis
- Patients must have elected for radiation with androgen deprivation therapy as the primary treatment modality for their prostate cancer
Exclusion
- Patients who are under 18 years of age are not eligible
- Patients who have a diagnosis of bladder cancer are not eligible.
- Patients with prior treatment for prostate cancer are not eligible.
- Patients with any type of prior prostate surgery (minimally invasive, endoscopic, or otherwise) including prior transurethral resection of the prostate (but excluding prior prostate biopsy) are ineligible.
- Patients with known metastatic prostate cancer are ineligible
- Patients who are enrolled in other surgical or international trials at the time of this study are not eligible
Key Trial Info
Start Date :
September 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2035
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03802851
Start Date
September 19 2019
End Date
January 1 2035
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Health System
Kansas City, Kansas, United States, 66160